mischley glutathione Laurie K Mischley, ND PhD MPH Laurie MISCHLEY | Faculty Member
Description
[DOI] [PMC free article] [PubMed] [Google Scholar] 3.Kierans S.J., Taylor C.T

Stepwise addition of the FOXO4-DRI peptide to this complex caused the CSPs of FOXO4 to be reverted back to the unbound state, indicating FOXO4-DRI competes with FOXO4 for p53 binding in a dose-dependent manner and doing so with higher affinity (Fig

The WIN-treated group showed significant reductions in the tumor size compared to the control group (Pennant and Hinton 2023)

This is due to additional depletion of the NADPH pool, which is already significantly reduced when ADP-heptose biosynthesis is inhibited [7], since the accumulation of cystine in the cell should increase the consumption of reducing equivalents (NADPH) for the reduction of cystine to cysteine [22]
